Related Experiment Video
Updated: Jun 19, 2025
Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Proteogenomic Workflow for Characterization of Microphthalmia Transcription Factor (MiT) Family Translocation Renal
Xiaoru Pei1, Xin Yan2, Chen Ding3
1Center for Cell and Gene Therapy, Clinical Research Center for Cell-based Immunotherapy, Shanghai Pudong Hospital, State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute , Fudan University, Shanghai, China.
Abstract:
Microphthalmia transcription factor (MiT) family translocation renal cell carcinoma (tRCC) is a rare, aggressive, and heterogeneous subtype of kidney cancer, which is not well characterized. Since genetic alterations are always associated with carcinogenesis, and proteins are the major executors of biological features, multi-omics studies can reveal the systematic tRCC biological process comprehensively. Here, we describe the proteogenomic workflow for characterization of tRCC in detail to provide the knowledge foundation for integrated proteogenomic analysis of tRCC and other malignant tumors in the future.
Insights
Microphthalmia transcription factor (MiT) family translocation renal cell carcinoma (tRCC) is a rare kidney cancer. This study details a proteogenomic workflow to comprehensively characterize tRCC, laying groundwork for future multi-omics research.
Area of Science:
- Oncology
- Genomics
- Proteomics
Background:
- Microphthalmia transcription factor (MiT) family translocation renal cell carcinoma (tRCC) is a rare, aggressive, and poorly characterized kidney cancer subtype.
- Understanding the molecular underpinnings of tRCC is crucial for developing effective treatments.
Purpose of the Study:
- To detail a proteogenomic workflow for the comprehensive characterization of tRCC.
- To establish a knowledge foundation for future integrated proteogenomic analyses of tRCC and other cancers.
Main Methods:
- Development and description of a multi-omics workflow integrating proteogenomic data.
- Application of the workflow for detailed characterization of tRCC.
Main Results:
- A detailed proteogenomic workflow for tRCC characterization has been established.
- The workflow provides a foundation for in-depth understanding of tRCC biology.
Conclusions:
- The described proteogenomic workflow enables comprehensive characterization of rare and aggressive cancers like tRCC.
- This approach is essential for advancing integrated multi-omics studies in oncology.
